Patient Capital Management LLC Boosts Stock Position in Canada Goose Holdings Inc. (NYSE:GOOS)

Patient Capital Management LLC boosted its position in Canada Goose Holdings Inc. (NYSE:GOOS) by 3.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,854,520 shares of the company’s stock after purchasing an additional 128,133 shares during the quarter. Canada Goose makes up approximately 1.8% of Patient Capital Management LLC’s investment portfolio, making the stock its 28th largest holding. Patient Capital Management LLC owned about 3.98% of Canada Goose worth $38,661,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of GOOS. Steward Partners Investment Advisory LLC raised its stake in shares of Canada Goose by 4,213.0% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 4,313 shares of the company’s stock worth $43,000 after acquiring an additional 4,213 shares in the last quarter. Deutsche Bank AG grew its holdings in Canada Goose by 192.0% in the fourth quarter. Deutsche Bank AG now owns 7,998 shares of the company’s stock worth $80,000 after purchasing an additional 5,259 shares during the last quarter. Virtu Financial LLC acquired a new position in shares of Canada Goose during the fourth quarter worth $100,000. Aigen Investment Management LP purchased a new stake in shares of Canada Goose during the 4th quarter valued at $103,000. Finally, Occudo Quantitative Strategies LP acquired a new stake in shares of Canada Goose in the 4th quarter worth $145,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Canada Goose Trading Up 1.8%

Shares of NYSE:GOOS opened at $9.20 on Wednesday. The company has a quick ratio of 1.14, a current ratio of 2.01 and a debt-to-equity ratio of 0.81. Canada Goose Holdings Inc. has a 52-week low of $6.73 and a 52-week high of $14.75. The stock has a market cap of $890.62 million, a price-to-earnings ratio of 17.69, a PEG ratio of 1.00 and a beta of 1.26. The business has a 50-day moving average price of $8.26 and a 200-day moving average price of $9.43.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on GOOS shares. Barclays reiterated an “underweight” rating and issued a $8.00 price target (down from $10.00) on shares of Canada Goose in a research note on Monday, March 31st. Wells Fargo & Company raised shares of Canada Goose from an “underweight” rating to an “equal weight” rating in a research report on Wednesday, April 30th. Finally, Evercore ISI dropped their target price on shares of Canada Goose from $13.00 to $10.00 and set an “in-line” rating on the stock in a research report on Monday, February 10th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $10.20.

Canada Goose Company Profile

Canada Goose Holdings Inc, together with its subsidiaries, designs, manufactures, and sells performance luxury apparel for men, women, youth, children, and babies in Canada, the United States, Asia Pacific, Europe, the Middle East, and Africa. The company operates through three segments: Direct-to-Consumer, Wholesale, and Other.